DEL GLOBAL TECHNOLOGIES CORP
8-K, 2001-01-04
ELECTRONIC COMPONENTS, NEC
Previous: TARGET CORP, 8-K, EX-20, 2001-01-04
Next: LIFECORE BIOMEDICAL INC, SC 13D/A, 2001-01-04



                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549
                    ----------------------------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                         Date of Report: January 4, 2001


                          DEL GLOBAL TECHNOLOGIES CORP.
                          -----------------------------
             (Exact name of registrant as specified in its charter)


                                     1-10512
                            (Commission File Number)


                                   13-1784308
                      (IRS Employer Identification Number)


                                    New York
                            (State of Incorporation)


                    1 Commerce Park, Valhalla, New York 10595
                    (Address of principal executive offices)


                                  914-686-3600
              (Registrant's Telephone Number, including area code)






<PAGE>



Item 5.           Other Events and Regulation FD Disclosure.
                  -----------------------------------------


                  The Registrant, a New York corporation ("Del"), issued a press
release dated January 4, 2001  announcing that it anticipates  achieving  record
revenues for Fiscal 2001 ending July 28, 2001 based on record orders received in
the August 2000 to December 2000 period. The Registrant is continuing its review
of  previously  reported  results  as well as its  efforts  to obtain  certified
financial  statements for the fiscal year ended July 29, 2000. The press release
is attached hereto as an exhibit and is incorporated herein by reference.

    Exhibits.

    Exhibit Number                                  Description

      20.1                                          Press Release of Del Global
                                                    Technologies Corp. dated
                                                    January 4, 2001



<PAGE>



                                   SIGNATURES


                  Pursuant to the requirements of the Securities Exchange Act of
1934,  the  Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.


                                         DEL GLOBAL TECHNOLOGIES CORP.



                                         By: s/Leonard A. Trugman
                                             ----------------------------------
Dated:  January 4, 2001                      Leonard A. Trugman, Chairman, Chief
                                             Executive Officer and President



<PAGE>

January 4, 2001                     FOR IMMEDIATE RELEASE



================================================================================
  DEL GLOBAL TECHNOLOGIES CORP. PROJECTS RECORD REVENUES FOR FISCAL 2001 BASED
                     UPON RECORD LEVELS OF INCOMING ORDERS
================================================================================


Valhalla,  NY, January 4, 2001 - Del Global  Technologies Corp. (DGTC) announced
it anticipates  achieving  record  revenues for Fiscal 2001 ending July 28, 2001
based on record orders received in the August 2000 to December 2000 period.

The Company indicated that incoming orders for the first 5 months of Fiscal 2001
ending December 31, 2000 are running substantially higher than the corresponding
period last year. Demand for products in the Del Power Conversion Group is at an
all time high and the  incoming  order  rate at its  Italian  subsidiary,  Villa
Sistemi  Medicali,  acquired  in April  2000,  is running  ahead of last  year's
comparable period.

The Company attributes its upturn in bookings to several factors:

o    The continuing  outsourcing trend for the design and manufacture of medical
     imaging  systems and critical  subsystems  by the world's  largest  imaging
     companies.

o    The Company's  operational  strengths in development and  manufacturing of
     new products.

o    The Company's  reputation for excellent  quality  coupled with cost
     effectiveness.

o    Aggressive  marketing by the Company of its  capabilities on a global
     basis.

In November  2000 the  Company's  Del Medical  Systems  Group  exhibited  at the
Radiological Society of North America ("RSNA") show in Chicago and at the Medica
Conference in Dusseldorf,  Germany.  At the RSNA show, Del won the No. 1 ranking
for price performance of its medical imaging systems.


[GRAPHIC OMITTED]


DEL GLOBAL TECHNOLOGIES CORP.
One Commerce Park, Valhalla, NY 10595
Tel: (914) 686-3600  Fax: (914) 686-5425

<PAGE>

The Company is continuing its review of previously  reported  results as well as
its efforts to obtain certified  financial  statements for the fiscal year ended
July 29, 2000. The Company's  Audit Committee has retained  independent  counsel
and  PricewaterhouseCoopers  LLP to  review  all  open  issues.  The  review  by
PricewaterhouseCoopers  and counsel is continuing.  In addition, the Company has
hired the law firm of Schulte Roth & Zabel to  represent  the Company in pending
class action suits.

The  Company  will  issue  a  further  press  release  announcing  when it has a
definitive  date for issuing  results  and will  schedule a  conference  call to
discuss  Fiscal 2000 once it files its Form 10-K and 10-Q.  The Company plans to
then apply for listing of its common stock on a national securities exchange.

Del Global  Technologies  Corp. is primarily engaged in the design,  manufacture
and marketing of state-of-the-art, cost-effective medical imaging and diagnostic
systems  consisting of stationary and portable  imaging  systems,  radiographic/
fluoroscopic  systems,  mammography systems,  Neo-Natal systems,  dental imaging
systems and  proprietary  precision power  conversion  subsystems for medical as
well as critical  industrial  applications.  These  include  airport  explosives
detection, electronic noise suppression subsystems,  analytical instrumentation,
semiconductor capital equipment and energy exploration.


This press release contains forward-looking  statements. Such statements involve
various risks that may cause actual  results to differ  materially.  These risks
include,  but are not limited to, the effect on the Company of ongoing  internal
reviews,  external  inquiries,  and class action  litigation  pertaining  to its
reported  financial  results,  the  ability of the  Company to obtain  certified
financial  statements,  to file required  annual and quarterly  reports,  and to
reattain an exchange  listing,  the ability of the Company to grow internally or
by  acquisition  and to integrate  acquired  businesses,  changing  industry and
competitive   conditions,   and  other  risks   referred  to  in  the  Company's
registration  statements  and periodic  reports  filed with the  Securities  and
Exchange Commission.


                                  EXHIBIT 20.1



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission